You are treating a 67-year-old woman with recurrent stage III ovarian cancer. Her performance status is excellent, and she desires “whatever you can do for her.” She has experienced disease progression, albeit slowly, despite treatment with carboplatin, taxol, gemcitabine, doxil, and topotecan. Do you offer